221 related articles for article (PubMed ID: 3745916)
21. Targeting Leishmania (L.) chagasi amastigotes through macrophage scavenger receptors: the use of drugs entrapped in liposomes containing phosphatidylserine.
Tempone AG; Perez D; Rath S; Vilarinho AL; Mortara RA; de Andrade HF
J Antimicrob Chemother; 2004 Jul; 54(1):60-8. PubMed ID: 15163652
[TBL] [Abstract][Full Text] [Related]
22. Involvement of protein kinase C and not of NF kappa B in the modulation of macrophage nitric oxide synthase by tumor-derived phosphatidyl serine.
Calderon CL; Torroella-Kouri M; Dinapoli MR; Lopez DM
Int J Oncol; 2008 Mar; 32(3):713-21. PubMed ID: 18292949
[TBL] [Abstract][Full Text] [Related]
23. Stearylamine-bearing cationic liposomes kill Leishmania parasites through surface exposed negatively charged phosphatidylserine.
Banerjee A; Roychoudhury J; Ali N
J Antimicrob Chemother; 2008 Jan; 61(1):103-10. PubMed ID: 17965031
[TBL] [Abstract][Full Text] [Related]
24. Resistance to macrophage-mediated killing as a factor influencing the pathogenesis of chronic cutaneous leishmaniasis.
Scott P; Sacks D; Sher A
J Immunol; 1983 Aug; 131(2):966-71. PubMed ID: 6863939
[TBL] [Abstract][Full Text] [Related]
25. A lymphokine distinct from interferon-gamma that activates human monocytes to kill Leishmania donovani in vitro.
Hoover DL; Finbloom DS; Crawford RM; Nacy CA; Gilbreath M; Meltzer MS
J Immunol; 1986 Feb; 136(4):1329-33. PubMed ID: 3080522
[TBL] [Abstract][Full Text] [Related]
26. The role of plasma membrane receptors and the kinetics of macrophage activation by lymphokines encapsulated in liposomes.
Fidler IJ; Raz A; Fogler WE; Hoyer LC; Poste G
Cancer Res; 1981 Feb; 41(2):495-504. PubMed ID: 7004633
[TBL] [Abstract][Full Text] [Related]
27. Involvement of ERK, a MAP kinase, in the production of TGF-beta by macrophages treated with liposomes composed of phosphatidylserine.
Otsuka M; Tsuchiya S; Aramaki Y
Biochem Biophys Res Commun; 2004 Nov; 324(4):1400-5. PubMed ID: 15504369
[TBL] [Abstract][Full Text] [Related]
28. Activation of tumoricidal properties in mouse macrophages by lymphokines encapsulated in liposomes.
Poste G; Kirsh R; Fogler WE; Fidler IJ
Cancer Res; 1979 Mar; 39(3):881-92. PubMed ID: 427777
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Reimão JQ; Colombo FA; Pereira-Chioccola VL; Tempone AG
Exp Parasitol; 2012 Mar; 130(3):195-9. PubMed ID: 22281156
[TBL] [Abstract][Full Text] [Related]
30. Involvement of macrophages in the eradication of established metastases following intravenous injection of liposomes containing macrophage activators.
Fidler IJ; Barnes Z; Fogler WE; Kirsh R; Bugelski P; Poste G
Cancer Res; 1982 Feb; 42(2):496-501. PubMed ID: 7055801
[TBL] [Abstract][Full Text] [Related]
31. In vivo activity of lymphokine-activated macrophages in host defense against neoplasia.
Fernandez-Cruz E; Ulich T; Schreiber RD
J Immunol; 1985 May; 134(5):3489-96. PubMed ID: 3920323
[TBL] [Abstract][Full Text] [Related]
32. Ca2+-calmodulin regulates the induction and expression of macrophage cytotoxicity.
Nguyen HK; Cain CA; Tompkins WA
J Biol Response Mod; 1987 Apr; 6(2):154-68. PubMed ID: 3585411
[TBL] [Abstract][Full Text] [Related]
33. Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes.
Fidler IJ; Fogler WE; Kleinerman ES; Saiki I
J Immunol; 1985 Dec; 135(6):4289-96. PubMed ID: 3934281
[TBL] [Abstract][Full Text] [Related]
34. The respiratory burst is not required for killing of intracellular and extracellular parasites by a lymphokine-activated macrophage cell line.
Scott P; James S; Sher A
Eur J Immunol; 1985 Jun; 15(6):553-8. PubMed ID: 2988973
[TBL] [Abstract][Full Text] [Related]
35. Cell contact-mediated macrophage activation for antileishmanial defense. I. Lymphocyte effector mechanism that is contact dependent and noncytotoxic.
Panosian CB; Sypek JP; Wyler DJ
J Immunol; 1984 Dec; 133(6):3358-65. PubMed ID: 6208278
[TBL] [Abstract][Full Text] [Related]
36. The contribution of a serum component(s) modified by B cells to the mechanism for macrophage activation by liposomes.
Aramaki Y; Murai M; Tsuchiya S
Immunology; 1993 Oct; 80(2):253-8. PubMed ID: 8262553
[TBL] [Abstract][Full Text] [Related]
37. [Effects of differently composed liposomes on pulmonary arterial pressure in sheep--involvement of pulmonary intravascular macrophages].
Miyamoto K; Nakano T; Aoi K; Aida A; Kawakami Y
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Oct; 29(10):1268-74. PubMed ID: 1753504
[TBL] [Abstract][Full Text] [Related]
38. Enhanced anticryptococcal activity of chloroquine in phosphatidylserine-containing liposomes in a murine model.
Khan MA; Jabeen R; Nasti TH; Mohammad O
J Antimicrob Chemother; 2005 Feb; 55(2):223-8. PubMed ID: 15590713
[TBL] [Abstract][Full Text] [Related]
39. Modulation of the biological activity of bacterial endotoxin by incorporation into liposomes.
Dijkstra J; Mellors JW; Ryan JL; Szoka FC
J Immunol; 1987 Apr; 138(8):2663-70. PubMed ID: 3494081
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidylserine and phosphatidylcholine-containing liposomes inhibit amyloid beta and interferon-gamma-induced microglial activation.
Hashioka S; Han YH; Fujii S; Kato T; Monji A; Utsumi H; Sawada M; Nakanishi H; Kanba S
Free Radic Biol Med; 2007 Apr; 42(7):945-54. PubMed ID: 17349923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
